The aim of this review was to define the place of stress echocardiography in the context of perfusion scintigraphy for the detection of coronary artery disease (CAD) and the assessment of cardiac risk. Stress echocardiography has the benefits of widespread availability, relatively low cost, portability, absence of radiation, and the determination of the ischaemic threshold. However, the echocardiographic windows are variable, sometimes with poor echogenicity, and interpretation is subjective and requires an adequate learning period.
Introduction
Stress echocardiography and myocardial perfusion scintigraphy are often used for the detection of coronary artery disease (CAD) and the assessment of cardiac risk . This review attempts to define the place of stress echocardiography in the context of perfusion scintigraphy. As a number of variables (referral bias, extent and severity of CAD, definition of significant CAD, stress protocols, medications) may potentially influence the results of either test, the comparisons will focus on studies involving performance of both echocardiographic and scintigraphic imaging in the same patients for each of the most widely used stress techniques: exercise, dobutamine, and the direct vasodilators adenosine and dipyridamole. For these comparisons to be valid, we assume that the investigators in these studies are equally expert in either technique.
Methods and Statistical Analysis
A MedLine search on stress echocardiographic and perfusion scintigraphic studies published in the major English language journals was performed, using the search terms (adenosine or dipyridamole or dobutamine or exercise) and (echocardiography or thallium or technetium). Studies were only included in the main diagnostic and prognostic analysis if both stress echocardiography and perfusion scintigraphy was performed in all patients, using the same cardiac stressor. Studies were only included in the diagnostic analysis if these studies included patients both with and without angiographically defined CAD, and if it was stated how many patients with and without CAD had negative and positive test results. Studies describing special issues such as women and patients with left bundle branch block (LBBB) of left ventricular hypertrophy (LVH) were excluded from the primary diagnostic analysis. Special issues such as these were discussed separately.
Sensitivity was defined as the number of true positive tests divided by the total number of patients with angiographically significant CAD. Specificity was defined as the number of true negative tests divided by the total number of patients without angiographically significant CAD. Mean values for sensitivity and specificity were calculated by combining the results of individual patient data from multiple studies. Comparisons of sensitivity and specificity were performed using the standardized normal distribution test. Statistical significance was defined as P<0·05.
Basic Principles of Stress Echocardiography Versus Perfusion Scintigraphy
In the presence of a flow-limiting coronary artery stenosis, exercise or pharmacological stress results in a sequence of functional events, known as the 'ischaemic cascade' [27] . According to this cascade, perfusion abnormalities (visualized at perfusion scintigraphy by relatively reduced tracer uptake) due to limited coronary flow reserve precede decreased myocardial contractility (visualized at echocardiography by abnormal regional systolic function).
The development of myocardial perfusion defects with either exercise or pharmacological stress depends on the induction of regional heterogeneity of myocardial blood flow. Coronary blood flow to the vascular bed of a normal artery dramatically increases during stress, whereas perfusion through a stenosed artery may change only minimally. Because the initial uptake of radiopharmaceuticals is flow-dependent within physiological ranges [28] , the relative myocardial radionuclide concentration will be greater in vascular beds supplied by a normal artery relative to that in beds perfused by an artery with significant obstruction.
Regional malperfusion severe enough to cause metabolic consequences of ischaemia can be identified by echocardiography, based upon the response of the left ventricle. The normal response of the left ventricle to exercise or dobutamine stress is to increase endocardial excursion, the speed of contraction, and the degree of myocardial thickening. The most important indices pointing to the presence of myocardial ischaemia include stress-induced deterioration of regional endocardial excursion, and a reduction of myocardial thickening.
Strengths and Limitations of Stress Echocardiography

Clinical Considerations
Several aspects of stress echocardiography are attractive from the standpoint of clinical feasibility. In comparison with scintigraphic cameras, echocardiography machines are widely available at relatively low cost, are smaller in size and are more portable. The shorter time for performance and interpretation of a stress echocardiogram is attractive in the outpatient setting. Finally, the absence of ionizing radiation may be attractive to the public, for some of whom nuclear tests have a bad image.
Imaging Considerations
Two-dimensional echocardiography provides the ability to visualize the heart using a non-invasive, real-time approach. As ischaemia may be observed on-line, appropriate action can be taken during the test. Documentation of the ischaemic threshold can provide important information about the severity and extent of underlying CAD. Non-ischaemic explanations for the patient symptoms may be apparent from the visualization of valve anatomy and gradients or pericardial effusion. Finally, specificity lowering (breast) attenuation artifacts at perfusion scintigraphy are not problematic with echocardiography. The relative weaknesses of stress echocardiography are the sometimes poor echocardiographic windows (especially in obese or lung emphysema patients), making a correct interpretation difficult or impossible, and the visual (subjective) interpretation, which requires an important learning curve even for experienced echocardiographers [29] [30] [31] .
Diagnostic Accuracy of the Imaging Modalities
Exercise Stress Echocardiography Versus Perfusion Scintigraphy Table 1 shows the sensitivity and specificity for the detection of CAD in seven studies [1] [2] [3] [4] [5] [6] [7] , directly comparing exercise echocardiography and perfusion scintigraphy in the same 397 patients. The sensitivities of both tests for the identification of CAD were comparable (78% vs 83%, respectively), although there was a higher sensitivity for perfusion scintigraphy in the setting of single vessel CAD (78% vs 67%, respectively, P<0·05).
There was a trend towards a better specificity for stress echocardiography (91% vs 83%, P<0·10).
Dobutamine Stress Echocardiography Versus Perfusion Scintigraphy
Also shown in Table 1 are the sensitivity and specificity values reported in eight studies [8] [9] [10] [11] [12] [13] [14] [15] , comprising 593 patients who underwent simultaneous dobutamine stress echocardiography and perfusion scintigraphy. Dobutamine stress perfusion scintigraphy was the more sensitive test: 86% vs 80% (P<0·05). Dobutamine stress echocardiography, however, was the more specific test: 86% vs 73% (P<0·005). The finding that stress perfusion scintigraphy is more sensitive (especially in patients with single vessel CAD) is in line with the ischaemic cascade theory [27] , which states that perfusion abnormalities due to limited coronary flow reserve precede wall motion abnormalities. That the difference in sensitivity between exercise or dobutamine stress echocardiography and perfusion scintigraphy is, in fact, only very small might be explained by two major factors: suboptimal inducement of blood flow heterogeneity by exercise or dobutamine [32] or inherent compensating strengths of echocardiography over perfusion scintigraphy, including improved spatial resolution, and the ability to categorize wall motion independently in each segment (contrasting with the relative blood flow comparisons used in myocardial perfusion imaging).
Vasodilator Stress Echocardiography Versus Perfusion Scintigraphy
As seen in Table 1 , pooled data from six studies [15] [16] [17] [18] [19] [20] [21] directly comparing vasodilator (adenosine or dipyridamole) stress echocardiography and perfusion scintigraphy in the same 390 patients show that the sensitivity of vasodilator perfusion scintigraphy was superior to that of vasodilator echocardiography (85% vs 66%, P<0·0001), both for single-vessel CAD (78% vs 58%,
P<0·01) and multivessel CAD (95% vs 74%, P<0·0001).
These results are not surprising, since vasodilators primarily create blood flow heterogeneity (detected by perfusion scintigraphy and not echocardiography) and true myocardial ischaemic (detected by echocardiography) in only a limited number of patients. Of note, not all studies [20] used optimal doses of vasodilator to induce true myocardial ischaemia [33] , and no single comparative study used the new, promising dipyridamole-atropine protocol 34] .
The Optimal Pharmacological Stressor
The necessity of inducing myocardial ischaemia for the development of wall motion abnormalities suggests that dobutamine may be more effective than a direct vasodilator for stress echocardiography [35] . Indeed, pooled data [36] from seven studies directly comparing (highdose) dobutamine vs (high-dose) dipyridamole or adenosine stress echocardiography showed that dobutamine stress echocardiography was the more sensitive test, while specificity was comparable. In contrast, direct vasodilators (adenosine or dipyridamole) are considered the most effective pharmacological drugs to create coronary blood flow heterogeneity [32, 35, 37] . The most appropriate means of comparing pharmacological stress echography and perfusion scintigraphy seems, therefore, to be to use dobutamine with the former and a direct vasodilator with the latter. Four studies have directly compared these two stress modalities [15, 18, 38, 39] . In only one study [15] was dipyridamole perfusion scintigraphy more sensitive than (high-dose) dobutamine stress echocardiography. Importantly, in all but one study {39] , dobutamine stress echocardiography tended to be more specific for the detection of CAD.
Assessment of the Localization of CAD
In Figure 1 , the sensitivities (Fig. 1A) and specificities ( Marwick [9] 1993 217 40 g/kg/min scintigraphy for individual vessels are shown as reported in eight studies (one report assessed two different stressors), for a total of 1,303 vessels (3, 6, 7, 11, 14, 15, 21) . The respective sensitivities were, respectively: 62% vs 72% (P<0·0001) for overall detection of individual CAD; 69% vs 73% for left anterior descending coronary disease; 43% vs 58% (P<0·005) for the left circumflex coronary disease, and 69% vs 82% (P<0·001) for right coronary disease. Specificities were, respectively, 90% vs 90%, 91% vs 92%, 92% vs 96%, and 88% vs 81%. For both stress echocardiography and perfusion scintigraphy, the sensitivity for detection of left circumflex coronary disease was (independent of the stressor) significantly less compared to detection of CAD in other coronary arteries. In addition to variation in coronary anatomy (with a small circumflex territory in some patients), perfusion scintigraphy suffers from a less reliable assessment of the posterior regions of the heart due to problems of photon attenuation, and echocardiography suffers from problems with resolution of the lateral wall endocardium because of the parallel orientation of this wall and the ultrasound beam. Overall differences in sensitivity for detection of individual vessel CAD between stress cardiography and perfusion scintigraphy were mainly caused by the included dipyridamole studies [15, 21] . When these studies were excluded from the analysis, overall sensitivity for detection of individual vessel, CAD was, respectively for stress echocardiography and perfusion scintigraphy, 69% vs 72%, and overall specificity was 90% for both imaging modalities.
Assessment of the Extent of CAD
An important goal of stress testing is the identification of patients with multivessel CAD, who could benefit from revascularization from a prognostic point of view [40] . Patients with multivessel CAD can be differentiated from patients with single vessel CAD by detection of wall motion or perfusion abnormalities in two or more coronary territories. The relative ability of stress echocardiography and perfusion scintigraphy to predict the extent of CAD has been investigated in four studies (one report assessed two different stressors) for a total of 220 patients [7, 11, 15] . The mean reported sensitivity for stress echocardiography (50%, range 14-70%) did not differ significantly from that reported for perfusion scintigraphy (58%, range 48-77%). However, analogous to the prior section, in one study [15] the sensitivity of dipyridamole echocardiography for multivessel CAD was clearly less than that of dipyridamole perfusion scintigraphy (14% vs 57%). The mean reported specificity for stress echocardiography (97%, range 90%-100%) was comparable to that reported for perfusion scintigraphy (95%, range 92%-100%). The relative underestimation of multivessel CAD by both imaging modalities can be explained by the premature cessation of stress because of the development of limiting ischaemia (angina, ST-segment deviation, or new wall motion abnormalities in one region as a test end-point during stress echocardiography), imperfect assignment of myocardial regions to coronary arteries, collateral circulations, anatomically significant but functionally non-significant lesions, and (for perfusion scintigraphy) diffuse hypoperfusion.
Special Subgroups
Left Bundle Branch Block
In LBBB patients, exercise perfusion scintigraphic studies often suffer from false positive perfusion defects in the interventricular septum in the absence of left anterior descending coronary stenosis [41] . Several mechanisms have been proposed to explain these perfusion defects. In LBBB patients, septal contraction occurs at the very end of systole. The regional myocardial compressive effect may restrict coronary blood flow during early diastole, when most perfusion normally occurs [42] . As the heart rate increases and diastole shortens, the relative septal hypoperfusion may become even more apparent. Alternatively, with markedly delayed septal contraction, the myocardium in this region encounters a decreased afterload to that of other left ventricular segments. This may result in a relative reduction in coronary septal blood flow as a result of coronary autoregulatory mechanisms [43] . Because of the suspected major role of heart rate increase in the development of septal defects, vasodilator (dipyridamole, adenosine) perfusion scintigraphy, which causes only a moderate increase in heart rate, is advocated as the stress test of choice [44] . Some promising reports on the value of stress echocardiography in LBBB patients have been published [45, 46] . In particular, in patients with preserved interventricular septal contraction (despite LBBB) dobutamine stress echocardiography may be a very accurate test to detect CAD in the left anterior descending coronary [46] . However, currently there are no studies directly comparing stress echocardiography with vasodilator perfusion scintigraphy.
Hypertension and/or Left Ventricular Hypertrophy
Hypertension is a major risk factor for CAD, and a frequent finding in patients undergoing stress testing. Several reports have suggested that the specificity of perfusion scintigraphy in patients with hypertension and/or LVH to detect CAD is suboptimal [47] [48] [49] . Perfusion defects despite the absence of obstructive epicardial CAD may be caused by a relative reduction in the microvascular bed size and a reduction in resistance vessels diameter secondary to vascular hypertrophy [50] . Although severely impaired perfusion may be expected to influence stress echocardiographic results also, several stress echocardiographic studies have shown excellent specificity values in patients with hypertension and/or Detection of CAD: Stress Echocardiography vs. Perfusion Scintigraphy 17 LVH [51] [52] [53] , comparable to values for patients without hypertension, studied in the same study [54] . Furthermore, the presence of LVH consistently did not affect the diagnostic accuracy of stress echocardiography in patients with hypertension [55] [56] [57] . Direct comparative studies with perfusion scintigraphy were mainly performed with dobutamine stress echocardiography [9, 53, 56] . In retrospective studies, variable results were reported concerning the value of this latter stress modality relative to dobutamine stress scintigraphy [9, 56] . In a large, prospective study, both dobutamine and dipyridamole stress echocardiography were more specific than exercise perfusion scintigraphy for the detection of CAD in patients with a history of hypertension [53] .
Women
The diagnosis of CAD in women may be troublesome, because they have (certainly until the seventh decade of life) a relatively low pre-test probability of CAD and a lower exercise capacity [58] . Perfusion scintigraphy may suffer from additional problems, such as anterolateral breast attenuation artifacts in rest or during stress in case of breast movement [59] , and the relatively small size of the female heart, given that the spatial resolution of perfusion scintigraphy is approximately 1 cm [60] . Several stress echocardiographic studies have shown excellent sensitivity and specificity values in women [61] [62] [63] , comparable to values for men, studied in the same study [63] .
Comparative studies with perfusion scintigraphy were only performed for dobutamine stress echocardiography [64] [65] [66] . In the studies using a high-dose dobutamine-atropine protocol, stress echocardiography was more accurate than dobutamine [65] and more specific than exercise/dipyridamole [64] perfusion scintigraphy.
Prognostic Accuracy of the Imaging Modalities
Although numerous studies have described the prognostic value of stress echocardiography [67] , only five prognostic studies [22] [23] [24] [25] [26] have directly compared the predictive value of this stress modality relative to perfusion scintigraphy. As seen in Table 2 , one study focused on patients after acute myocardial infarction [22] , two studies focused on patients with known or suspected stable CAD [23, 24] , and another two studies [25, 26] focused on patients assessed before undergoing major surgery, describing the prediction of perioperative events. In none of these studies was a significant difference found between stress echocardiography and perfusion scintigraphy, as measured by the risk ratio of a positive test over a negative test for the occurrence of cardiac events, although in the preoperative era perfusion scintigraphy tended to perform somewhat better. In both studies in patients with known or suspected stable CAD [23, 24] , a positive echocardiographic or scintigraphic study not only increased subsequent cardiac risk in absolute terms, but the extent of wall motion abnormalities was at least as discriminative as the extent of perfusion abnormalities to further stratify patients into intermediate and high-risk subsets. Most importantly, patients with a normal stress echocardiogram or perfusion scintigram had a comparable annual hard (cardiac death or nonfatal myocardial infarction) event rate of less than 1%. Thus, both stress echocardiography and stress perfusion scintigraphy may identify a group of patients at low risk for future cardiac events in whom no further (more invasive) tests are required.
Conclusions and Recommendations
This review has concentrated on direct comparisons of stress echocardiography and perfusion scintigraphy for the diagnosis of CAD and the assessment of cardiac risk. As described, stress echocardiography has some relative strengths and limitations For the moment stress echocardiography (in particular when vasodilators are used) seems somewhat less sensitive to detecting and localizing (mild) CAD, but seems the more specific test. These findings may partly be explained by the relative low stressor dose used in some studies [8, 20] , since it is well known that stress echocardiography is more vulnerable to submaximal stress [33, 68, 69] . However, it should also be noted that many scintigraphic studies were not performed with the newest technetium-99m SPECT technology. For prognostic purposes, more related to severe forms of CAD, stress echocardiography and perfusion scintigraphy seem to have comparable strength. At this moment we recommend the following guidelines for the use of the two imaging modalities (disregarding costs and assuming equal available expertise for both modalities).
Perfusion scintigraphy is more useful in: v patients with a poor echocardiographic window (obese, airway disease); v patients with a high pre-test probability of CAD; v patients requiring vasodilator stress; v patients with LBBB (in combination with a direct vasodilator); v detection of (anatomically defined) mild CAD.
Echocardiography is more useful in: v patients in whom safety is a major concern; v assessment of the functional significance of a known stenosis; v patients with a low pre-test probability of CAD; v patients with a suspicion of significant valvular, myocardial or pericardial disease.
Echocardiography may be more useful in: v patients with hypertension and/or left ventricular hypertrophy; v women.
In the near future, many technical improvements are expected to improve the value of stress echocardiography further. In particular, changes in stress protocols, such as the addition of atropine to dobutamine [70] or dipyridamole [34] , improvement in endocardial border detection with second harmonic imaging [71] and contrast echocardiography [72] , and quantitation of wall motion analysis to provide objective data with colour kinesis [73] or tissue Doppler imaging [74] are expected to improve the value of stress echocardiography still further.
